Final USPSTF Recommendation on Breast Cancer Screening Lowers Starting Age from 50 to 40 Years, Highlights Racial DisparitiesHalsey, GracePatient Care (Online)
The new USPSTF breast cancer screening guidelines recommend that women start regular mammograms at age 40, which is a shift from the previous recommendation of starting at age 50. However, the new guidelines suggest screenings every two years rather than annually. Prabakar expressed mixe...
What type of cervical cancer screening should a woman get, if any, and how often? The latest recommendation from the United States Preventive Services Task Force (USPSTF) said Tuesday that it depends on a woman’s age and other factors, but those 30 or older have a new option. ...
“What this recommendation means is that, overall on a population level, there is a small net benefit from prostate cancer screenings,”Alex H.Krist, MD, MPH,associate professor of family medicine and population health at Virginia Commonwealth Universit...
recommendationson practicingsurgeonsfound that 88% of breast surgeons and 82% of general surgeons continue to recommend annual mammography for women with an average risk of developingbreast cancer. An even greater percentage—93%—reported that they began or would begin annual screenings for themselves...
Rates of PSA screening, prostate biopsy and overall prostate cancer incidence declined in the first few years after the recommendation, with a shift towards higher grade and stage of prostate tumours at the time of detection Despite the recommendation, some physicians report ongoing willingness to scr...
The latest recommendation from the United States Preventive Services Task Force said cervical cancer screening depends on a woman’s age and other factors.
“This recommendation moves the United States closer to common ground with all of the major countries in Europe and Australia who began implementing primary HPV screening programs some time ago.” The USPSTF concluded that “there are no clinically important differences between liquid-based cytology ...
offer to prescribe risk-reducing medications for women who are at increased risk for breast cancer and have low risk for adverse medication events (B recommendation). Risk-reducing medications should not be used routinely for women who are not at increased risk for cancer (D recommendation). ...
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of adjunctive screening for breast... AL Siu - 《Annals of Internal Medicine》 被引量...